Rank | Gene Set | Z-score |
---|---|---|
1 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.84147621 |
2 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.84147621 |
3 | modulation by symbiont of host immune response (GO:0052553) | 6.84147621 |
4 | positive regulation by symbiont of host defense response (GO:0052509) | 6.84147621 |
5 | modulation by symbiont of host defense response (GO:0052031) | 6.84147621 |
6 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.84147621 |
7 | regulation of interferon-beta biosynthetic process (GO:0045357) | 6.01600189 |
8 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.09420222 |
9 | macrophage activation involved in immune response (GO:0002281) | 5.08698009 |
10 | neutrophil activation involved in immune response (GO:0002283) | 5.07947717 |
11 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 4.87744298 |
12 | positive regulation of interferon-alpha production (GO:0032727) | 4.76036894 |
13 | regulation of interferon-alpha production (GO:0032647) | 4.52323953 |
14 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 4.44709332 |
15 | response to host immune response (GO:0052572) | 4.38283353 |
16 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.38283353 |
17 | immunoglobulin mediated immune response (GO:0016064) | 4.37966255 |
18 | microglial cell activation (GO:0001774) | 4.24233227 |
19 | glycosphingolipid catabolic process (GO:0046479) | 4.20057915 |
20 | respiratory burst (GO:0045730) | 4.08835241 |
21 | response to peptidoglycan (GO:0032494) | 4.07473264 |
22 | response to host (GO:0075136) | 3.99305262 |
23 | response to host defenses (GO:0052200) | 3.99305262 |
24 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.99305262 |
25 | pinocytosis (GO:0006907) | 3.98408610 |
26 | regulation of cholesterol storage (GO:0010885) | 3.90276048 |
27 | apoptotic cell clearance (GO:0043277) | 3.83278754 |
28 | mannose metabolic process (GO:0006013) | 3.82473380 |
29 | regulation of mononuclear cell migration (GO:0071675) | 3.79416316 |
30 | amino sugar catabolic process (GO:0046348) | 3.78039805 |
31 | glycolipid catabolic process (GO:0019377) | 3.76266774 |
32 | detection of other organism (GO:0098543) | 3.74180531 |
33 | oligosaccharide catabolic process (GO:0009313) | 3.71986836 |
34 | positive regulation of antigen processing and presentation (GO:0002579) | 3.71968382 |
35 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.70377245 |
36 | macrophage activation (GO:0042116) | 3.68585715 |
37 | detection of bacterium (GO:0016045) | 3.60375742 |
38 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.55101092 |
39 | myeloid cell activation involved in immune response (GO:0002275) | 3.53940208 |
40 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.44897805 |
41 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.44897805 |
42 | negative regulation of cell killing (GO:0031342) | 3.43836157 |
43 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.43836157 |
44 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.43175663 |
45 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.40540055 |
46 | low-density lipoprotein particle clearance (GO:0034383) | 3.36820823 |
47 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.33379001 |
48 | positive regulation of interferon-beta production (GO:0032728) | 3.30366786 |
49 | barbed-end actin filament capping (GO:0051016) | 3.29269440 |
50 | detection of external biotic stimulus (GO:0098581) | 3.28366099 |
51 | ceramide catabolic process (GO:0046514) | 3.25854776 |
52 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.24990413 |
53 | regulation of antigen processing and presentation (GO:0002577) | 3.23838650 |
54 | granulocyte activation (GO:0036230) | 3.22737929 |
55 | NIK/NF-kappaB signaling (GO:0038061) | 3.22148383 |
56 | positive regulation of mast cell activation (GO:0033005) | 3.21015232 |
57 | I-kappaB phosphorylation (GO:0007252) | 3.19733372 |
58 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.16953700 |
59 | T-helper 1 type immune response (GO:0042088) | 3.16704413 |
60 | hyaluronan catabolic process (GO:0030214) | 3.15828049 |
61 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.15791592 |
62 | detection of molecule of bacterial origin (GO:0032490) | 3.15372481 |
63 | regulation of mast cell degranulation (GO:0043304) | 3.14406623 |
64 | B cell mediated immunity (GO:0019724) | 3.14322509 |
65 | cellular extravasation (GO:0045123) | 3.13912860 |
66 | myeloid dendritic cell differentiation (GO:0043011) | 3.12990323 |
67 | neutrophil activation (GO:0042119) | 3.11737529 |
68 | protein localization to endosome (GO:0036010) | 3.07280531 |
69 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.05200298 |
70 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.03176894 |
71 | keratan sulfate catabolic process (GO:0042340) | 3.01219423 |
72 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.00767133 |
73 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.97550308 |
74 | response to interferon-alpha (GO:0035455) | 2.97509141 |
75 | positive regulation of leukocyte degranulation (GO:0043302) | 2.97163983 |
76 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.97035639 |
77 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.95586979 |
78 | N-acetylneuraminate metabolic process (GO:0006054) | 2.95441456 |
79 | regulation of superoxide anion generation (GO:0032928) | 2.90515322 |
80 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.90504769 |
81 | response to thyroid hormone (GO:0097066) | 2.87427591 |
82 | detection of biotic stimulus (GO:0009595) | 2.86802729 |
83 | regulation of podosome assembly (GO:0071801) | 2.86261214 |
84 | germinal center formation (GO:0002467) | 2.86128754 |
85 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.85853936 |
86 | negative regulation of granulocyte differentiation (GO:0030853) | 2.85460111 |
87 | regulation of mast cell activation (GO:0033003) | 2.85277015 |
88 | regulation of leukocyte degranulation (GO:0043300) | 2.83123445 |
89 | positive regulation of mast cell degranulation (GO:0043306) | 2.83065825 |
90 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.83065825 |
91 | myeloid dendritic cell activation (GO:0001773) | 2.82761978 |
92 | response to muramyl dipeptide (GO:0032495) | 2.82356157 |
93 | regulation of macrophage chemotaxis (GO:0010758) | 2.82056344 |
94 | positive regulation of B cell differentiation (GO:0045579) | 2.80490944 |
95 | membrane lipid catabolic process (GO:0046466) | 2.80083040 |
96 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.79666697 |
97 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.78941906 |
98 | response to laminar fluid shear stress (GO:0034616) | 2.77476908 |
99 | sphingolipid catabolic process (GO:0030149) | 2.77180314 |
100 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.75145939 |
101 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.74952503 |
102 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.74441993 |
103 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.72661005 |
104 | peptide catabolic process (GO:0043171) | 2.70216337 |
105 | negative regulation of interleukin-6 production (GO:0032715) | 2.69890563 |
106 | negative regulation of mast cell activation (GO:0033004) | 2.69494866 |
107 | virion attachment to host cell (GO:0019062) | 2.68152726 |
108 | adhesion of symbiont to host cell (GO:0044650) | 2.68152726 |
109 | natural killer cell mediated immunity (GO:0002228) | 2.66813720 |
110 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.66813720 |
111 | lymphocyte chemotaxis (GO:0048247) | 2.66306894 |
112 | reactive oxygen species biosynthetic process (GO:1903409) | 2.66105249 |
113 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.65976823 |
114 | regulation of phagocytosis (GO:0050764) | 2.64637703 |
115 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.64548960 |
116 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.63976907 |
117 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.63860235 |
118 | cell adhesion mediated by integrin (GO:0033627) | 2.62820223 |
119 | type I interferon signaling pathway (GO:0060337) | 2.62522115 |
120 | cellular response to type I interferon (GO:0071357) | 2.62522115 |
121 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.61471310 |
122 | response to type I interferon (GO:0034340) | 2.61315471 |
123 | regulation of macrophage cytokine production (GO:0010935) | 2.59998183 |
124 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.59996735 |
125 | neutrophil mediated immunity (GO:0002446) | 2.58695806 |
126 | myeloid leukocyte activation (GO:0002274) | 2.58553417 |
127 | regulation of regulated secretory pathway (GO:1903305) | 2.58454681 |
128 | regulation of interferon-beta production (GO:0032648) | 2.58299125 |
129 | negative regulation of interleukin-12 production (GO:0032695) | 2.57095024 |
130 | lipoprotein transport (GO:0042953) | 2.56879581 |
131 | superoxide anion generation (GO:0042554) | 2.56847278 |
132 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.55948039 |
133 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.54919361 |
134 | regulation of chemokine biosynthetic process (GO:0045073) | 2.54832448 |
135 | dendritic cell differentiation (GO:0097028) | 2.54513007 |
136 | cellular response to interferon-alpha (GO:0035457) | 2.54335229 |
137 | positive regulation of macrophage cytokine production (GO:0060907) | 2.53870926 |
138 | positive regulation of phagocytosis (GO:0050766) | 2.53696157 |
139 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.53447827 |
140 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.52198489 |
141 | negative regulation of lipid storage (GO:0010888) | 2.50861685 |
142 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.50670850 |
143 | amyloid precursor protein catabolic process (GO:0042987) | 2.50168135 |
144 | regulation of integrin activation (GO:0033623) | 2.50053422 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.91905804 |
2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.04998207 |
3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.72360021 |
4 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.20568294 |
5 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.90263441 |
6 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.57221064 |
7 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.38350153 |
8 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.06447954 |
9 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 3.06275421 |
10 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.01960094 |
11 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.91024653 |
12 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.65807178 |
13 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.55889262 |
14 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.53000271 |
15 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.35155814 |
16 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.23556719 |
17 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.20859151 |
18 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.08890028 |
19 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.07388748 |
20 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.01674428 |
21 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.00363369 |
22 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.97656412 |
23 | SPI1_23127762_ChIP-Seq_K562_Human | 1.95414552 |
24 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.83655859 |
25 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.81988475 |
26 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.80082601 |
27 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.77825478 |
28 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.76217977 |
29 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.73294883 |
30 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.72714066 |
31 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.70054602 |
32 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.69566914 |
33 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.69498707 |
34 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.65296148 |
35 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.63564330 |
36 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.63521250 |
37 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.61949505 |
38 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.60588477 |
39 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.59270736 |
40 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.58232943 |
41 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.56541495 |
42 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.56236442 |
43 | MAF_26560356_Chip-Seq_TH1_Human | 1.55465867 |
44 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.50595780 |
45 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.50561884 |
46 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.50172007 |
47 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.45992336 |
48 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.45458118 |
49 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.44953360 |
50 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.44222200 |
51 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.42880636 |
52 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.42608644 |
53 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.38230756 |
54 | MYB_26560356_Chip-Seq_TH2_Human | 1.37773698 |
55 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.37525447 |
56 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.36677526 |
57 | * TFEB_21752829_ChIP-Seq_HELA_Human | 1.35801807 |
58 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.35716501 |
59 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.34947747 |
60 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.34132032 |
61 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.31892978 |
62 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.28368935 |
63 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.28020638 |
64 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.26610742 |
65 | GATA1_22025678_ChIP-Seq_K562_Human | 1.24548889 |
66 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.23411847 |
67 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.22286186 |
68 | MAF_26560356_Chip-Seq_TH2_Human | 1.20816400 |
69 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.18881862 |
70 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.18652709 |
71 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.17161086 |
72 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.15750180 |
73 | MYB_26560356_Chip-Seq_TH1_Human | 1.14375499 |
74 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.14372203 |
75 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.14337729 |
76 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.13726670 |
77 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.13473937 |
78 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.13112759 |
79 | UTX_26944678_Chip-Seq_JUKART_Human | 1.12758157 |
80 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.12734881 |
81 | MYC_22102868_ChIP-Seq_BL_Human | 1.11884881 |
82 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.11558216 |
83 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.11477567 |
84 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.11259904 |
85 | KDM2B_26808549_Chip-Seq_K562_Human | 1.11109840 |
86 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.10800030 |
87 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10762995 |
88 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.08705020 |
89 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.08106198 |
90 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.07269783 |
91 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.06537708 |
92 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.05137819 |
93 | * NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.04864704 |
94 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.04777126 |
95 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.04452822 |
96 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.03681182 |
97 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.03068915 |
98 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.02500698 |
99 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.02390314 |
100 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.00729606 |
101 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.00326288 |
102 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.99288429 |
103 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.98806050 |
104 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.97025337 |
105 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.95141338 |
106 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.94349141 |
107 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.93279720 |
108 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.92191619 |
109 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.90714914 |
110 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90249335 |
111 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.90099969 |
112 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.87138842 |
113 | GATA1_19941826_ChIP-Seq_K562_Human | 0.86844493 |
114 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.86438932 |
115 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.86316298 |
116 | GATA3_26560356_Chip-Seq_TH2_Human | 0.86244372 |
117 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.85610520 |
118 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.85344954 |
119 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.84382101 |
120 | GATA2_19941826_ChIP-Seq_K562_Human | 0.82985727 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0005058_abnormal_lysosome_morphology | 5.12449674 |
2 | MP0003303_peritoneal_inflammation | 3.56863327 |
3 | MP0001835_abnormal_antigen_presentation | 3.36743543 |
4 | MP0003436_decreased_susceptibility_to | 3.36407875 |
5 | MP0006082_CNS_inflammation | 3.22465290 |
6 | MP0009840_abnormal_foam_cell | 3.22026851 |
7 | MP0003172_abnormal_lysosome_physiology | 3.12929421 |
8 | * MP0002419_abnormal_innate_immunity | 2.70543083 |
9 | MP0003191_abnormal_cellular_cholesterol | 2.65954651 |
10 | MP0008438_abnormal_cutaneous_collagen | 2.51468253 |
11 | MP0002148_abnormal_hypersensitivity_rea | 2.37200560 |
12 | MP0005000_abnormal_immune_tolerance | 2.31422457 |
13 | MP0003300_gastrointestinal_ulcer | 2.18477410 |
14 | MP0005387_immune_system_phenotype | 2.17229523 |
15 | MP0001790_abnormal_immune_system | 2.17229523 |
16 | MP0003724_increased_susceptibility_to | 2.16180711 |
17 | MP0009785_altered_susceptibility_to | 2.14654451 |
18 | MP0001533_abnormal_skeleton_physiology | 2.14370422 |
19 | * MP0005025_abnormal_response_to | 2.13940614 |
20 | MP0005451_abnormal_body_composition | 2.12026719 |
21 | MP0005464_abnormal_platelet_physiology | 2.10207532 |
22 | * MP0002452_abnormal_antigen_presenting | 2.06379998 |
23 | MP0001800_abnormal_humoral_immune | 1.89271329 |
24 | MP0000343_altered_response_to | 1.88723248 |
25 | MP0000685_abnormal_immune_system | 1.88427873 |
26 | MP0000604_amyloidosis | 1.88224060 |
27 | MP0008260_abnormal_autophagy | 1.83397063 |
28 | MP0003705_abnormal_hypodermis_morpholog | 1.81417462 |
29 | MP0005257_abnormal_intraocular_pressure | 1.79734406 |
30 | * MP0002723_abnormal_immune_serum | 1.77593152 |
31 | MP0004510_myositis | 1.77166903 |
32 | MP0002139_abnormal_hepatobiliary_system | 1.71887922 |
33 | * MP0001819_abnormal_immune_cell | 1.60604289 |
34 | * MP0002420_abnormal_adaptive_immunity | 1.58995922 |
35 | MP0003448_altered_tumor_morphology | 1.58712999 |
36 | MP0003566_abnormal_cell_adhesion | 1.58458947 |
37 | MP0004947_skin_inflammation | 1.55357554 |
38 | MP0001845_abnormal_inflammatory_respons | 1.55200472 |
39 | MP0003075_altered_response_to | 1.52402837 |
40 | MP0008469_abnormal_protein_level | 1.51299901 |
41 | MP0002405_respiratory_system_inflammati | 1.51173384 |
42 | MP0003806_abnormal_nucleotide_metabolis | 1.47430661 |
43 | MP0009278_abnormal_bone_marrow | 1.46536156 |
44 | MP0010307_abnormal_tumor_latency | 1.40087351 |
45 | MP0002998_abnormal_bone_remodeling | 1.39842409 |
46 | MP0005671_abnormal_response_to | 1.39495848 |
47 | MP0001958_emphysema | 1.31731808 |
48 | MP0000858_altered_metastatic_potential | 1.30525752 |
49 | MP0002877_abnormal_melanocyte_morpholog | 1.30366130 |
50 | MP0009764_decreased_sensitivity_to | 1.26630977 |
51 | * MP0003690_abnormal_glial_cell | 1.26622570 |
52 | MP0005310_abnormal_salivary_gland | 1.25227767 |
53 | MP0001851_eye_inflammation | 1.24038440 |
54 | MP0008004_abnormal_stomach_pH | 1.23137113 |
55 | MP0003329_amyloid_beta_deposits | 1.23131218 |
56 | MP0003183_abnormal_peptide_metabolism | 1.22721682 |
57 | MP0010155_abnormal_intestine_physiology | 1.22109210 |
58 | MP0009333_abnormal_splenocyte_physiolog | 1.16849018 |
59 | MP0005390_skeleton_phenotype | 1.16303395 |
60 | MP0000689_abnormal_spleen_morphology | 1.16098769 |
61 | MP0005166_decreased_susceptibility_to | 1.15245770 |
62 | * MP0000716_abnormal_immune_system | 1.15151716 |
63 | MP0000569_abnormal_digit_pigmentation | 1.14325374 |
64 | MP0000465_gastrointestinal_hemorrhage | 1.12794377 |
65 | MP0001853_heart_inflammation | 1.11730286 |
66 | MP0001849_ear_inflammation | 1.09734382 |
67 | MP0005164_abnormal_response_to | 1.08998036 |
68 | MP0002933_joint_inflammation | 1.06833838 |
69 | MP0005023_abnormal_wound_healing | 1.04670933 |
70 | MP0005397_hematopoietic_system_phenotyp | 1.03792567 |
71 | MP0001545_abnormal_hematopoietic_system | 1.03792567 |
72 | MP0003656_abnormal_erythrocyte_physiolo | 1.03500764 |
73 | MP0002398_abnormal_bone_marrow | 1.01332647 |
74 | MP0003279_aneurysm | 0.99812773 |
75 | * MP0002429_abnormal_blood_cell | 0.97607494 |
76 | MP0003828_pulmonary_edema | 0.97586717 |
77 | MP0002166_altered_tumor_susceptibility | 0.96511597 |
78 | MP0002722_abnormal_immune_system | 0.95195427 |
79 | MP0000249_abnormal_blood_vessel | 0.94679457 |
80 | MP0005076_abnormal_cell_differentiation | 0.93662081 |
81 | MP0005083_abnormal_biliary_tract | 0.92467578 |
82 | MP0009763_increased_sensitivity_to | 0.91338416 |
83 | MP0000920_abnormal_myelination | 0.89293813 |
84 | MP0000609_abnormal_liver_physiology | 0.89078687 |
85 | MP0000767_abnormal_smooth_muscle | 0.88525767 |
86 | MP0003091_abnormal_cell_migration | 0.87564496 |
87 | MP0002254_reproductive_system_inflammat | 0.84033618 |
88 | MP0004883_abnormal_blood_vessel | 0.82997275 |
89 | MP0003795_abnormal_bone_structure | 0.82345269 |
90 | MP0002090_abnormal_vision | 0.82286802 |
91 | MP0010329_abnormal_lipoprotein_level | 0.82283426 |
92 | MP0003186_abnormal_redox_activity | 0.80844838 |
93 | MP0005167_abnormal_blood-brain_barrier | 0.80741565 |
94 | MP0005365_abnormal_bile_salt | 0.79963246 |
95 | MP0005275_abnormal_skin_tensile | 0.79754575 |
96 | MP0002138_abnormal_hepatobiliary_system | 0.78999467 |
97 | MP0000598_abnormal_liver_morphology | 0.77705139 |
98 | MP0004185_abnormal_adipocyte_glucose | 0.77626985 |
99 | MP0002136_abnormal_kidney_physiology | 0.77073038 |
100 | MP0004782_abnormal_surfactant_physiolog | 0.75642018 |
101 | MP0005319_abnormal_enzyme/_coenzyme | 0.75335453 |
102 | MP0004130_abnormal_muscle_cell | 0.75257264 |
103 | MP0004858_abnormal_nervous_system | 0.75198479 |
104 | MP0000490_abnormal_crypts_of | 0.75129556 |
105 | MP0003195_calcinosis | 0.74015582 |
106 | MP0003453_abnormal_keratinocyte_physiol | 0.73421472 |
107 | MP0001915_intracranial_hemorrhage | 0.72998560 |
108 | MP0001663_abnormal_digestive_system | 0.72627430 |
109 | MP0005670_abnormal_white_adipose | 0.72508656 |
110 | MP0005174_abnormal_tail_pigmentation | 0.70304287 |
111 | * MP0005165_increased_susceptibility_to | 0.70133352 |
112 | MP0001542_abnormal_bone_strength | 0.69740201 |
113 | MP0002006_tumorigenesis | 0.69722064 |
114 | MP0006054_spinal_hemorrhage | 0.67924372 |
115 | MP0010234_abnormal_vibrissa_follicle | 0.66693594 |
116 | MP0003763_abnormal_thymus_physiology | 0.65154265 |
117 | MP0003634_abnormal_glial_cell | 0.64987557 |
118 | MP0000371_diluted_coat_color | 0.63921701 |
119 | MP0008874_decreased_physiological_sensi | 0.62265119 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Increased cerebral lipofuscin (HP:0011813) | 6.50209222 |
2 | Systemic lupus erythematosus (HP:0002725) | 6.19068105 |
3 | Vacuolated lymphocytes (HP:0001922) | 6.06083556 |
4 | Recurrent abscess formation (HP:0002722) | 5.77006944 |
5 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 5.70225033 |
6 | Dysostosis multiplex (HP:0000943) | 5.38183889 |
7 | Eczematoid dermatitis (HP:0000976) | 5.28230487 |
8 | Recurrent bacterial skin infections (HP:0005406) | 5.20310255 |
9 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.91593785 |
10 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.60351700 |
11 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.60351700 |
12 | Abnormality of glycolipid metabolism (HP:0010969) | 4.60351700 |
13 | Abnormality of macrophages (HP:0004311) | 4.48253833 |
14 | Mucopolysacchariduria (HP:0008155) | 4.47764013 |
15 | Urinary glycosaminoglycan excretion (HP:0003541) | 4.47764013 |
16 | Glomerulonephritis (HP:0000099) | 4.38333979 |
17 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 4.21295271 |
18 | Abnormality of polysaccharide metabolism (HP:0011012) | 4.21295271 |
19 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 4.21295271 |
20 | Axonal loss (HP:0003447) | 4.05051464 |
21 | Loss of speech (HP:0002371) | 3.54756372 |
22 | Complement deficiency (HP:0004431) | 3.50052511 |
23 | Abnormality of complement system (HP:0005339) | 3.41711083 |
24 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.35933048 |
25 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.27034500 |
26 | Myocardial infarction (HP:0001658) | 3.13242856 |
27 | Nuclear cataract (HP:0100018) | 3.04890097 |
28 | Neurofibrillary tangles (HP:0002185) | 3.04791979 |
29 | Gingivitis (HP:0000230) | 3.02697440 |
30 | Recurrent skin infections (HP:0001581) | 3.02536732 |
31 | Purpura (HP:0000979) | 2.96718022 |
32 | Nephritis (HP:0000123) | 2.87951330 |
33 | Myositis (HP:0100614) | 2.86643194 |
34 | Obstructive lung disease (HP:0006536) | 2.86148788 |
35 | Chronic obstructive pulmonary disease (HP:0006510) | 2.86148788 |
36 | Mediastinal lymphadenopathy (HP:0100721) | 2.82992195 |
37 | Asymmetric septal hypertrophy (HP:0001670) | 2.78460410 |
38 | Agnosia (HP:0010524) | 2.76663521 |
39 | Pustule (HP:0200039) | 2.65608867 |
40 | J-shaped sella turcica (HP:0002680) | 2.65183598 |
41 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.62948891 |
42 | Interstitial pulmonary disease (HP:0006530) | 2.61088716 |
43 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.56127245 |
44 | Vertebral compression fractures (HP:0002953) | 2.55985527 |
45 | Upper motor neuron abnormality (HP:0002127) | 2.55709733 |
46 | Hepatosplenomegaly (HP:0001433) | 2.54857825 |
47 | Cellulitis (HP:0100658) | 2.54656809 |
48 | * Disinhibition (HP:0000734) | 2.52299916 |
49 | Cerebral aneurysm (HP:0004944) | 2.51616756 |
50 | Thoracic kyphosis (HP:0002942) | 2.50385770 |
51 | Pathologic fracture (HP:0002756) | 2.50311278 |
52 | Abnormality of the lumbar spine (HP:0100712) | 2.47377122 |
53 | Autoimmune thrombocytopenia (HP:0001973) | 2.46748039 |
54 | Orchitis (HP:0100796) | 2.45271508 |
55 | Recurrent fungal infections (HP:0002841) | 2.42697523 |
56 | Basal ganglia calcification (HP:0002135) | 2.41221719 |
57 | Cervical subluxation (HP:0003308) | 2.38751021 |
58 | Spontaneous hematomas (HP:0007420) | 2.36234293 |
59 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.35939323 |
60 | Osteolytic defects of the hand bones (HP:0009699) | 2.35939323 |
61 | Hematochezia (HP:0002573) | 2.34297682 |
62 | Cerebral inclusion bodies (HP:0100314) | 2.31466784 |
63 | Urticaria (HP:0001025) | 2.30211928 |
64 | Conjunctival telangiectasia (HP:0000524) | 2.29528027 |
65 | Spondylolisthesis (HP:0003302) | 2.25354458 |
66 | Premature rupture of membranes (HP:0001788) | 2.20547689 |
67 | Periodontitis (HP:0000704) | 2.20081428 |
68 | Thick nail (HP:0001805) | 2.18525804 |
69 | Prolonged neonatal jaundice (HP:0006579) | 2.17666857 |
70 | Joint hemorrhage (HP:0005261) | 2.17313077 |
71 | Pulmonary infiltrates (HP:0002113) | 2.16016129 |
72 | Chronic otitis media (HP:0000389) | 2.15894132 |
73 | Recurrent viral infections (HP:0004429) | 2.14952082 |
74 | Prostate neoplasm (HP:0100787) | 2.09892699 |
75 | Osteomyelitis (HP:0002754) | 2.08492689 |
76 | Joint stiffness (HP:0001387) | 2.07967021 |
77 | Increased IgE level (HP:0003212) | 2.06801405 |
78 | Peripheral demyelination (HP:0011096) | 2.05519443 |
79 | Malnutrition (HP:0004395) | 2.04249117 |
80 | Meningitis (HP:0001287) | 2.02293785 |
81 | Ovoid vertebral bodies (HP:0003300) | 2.02137011 |
82 | Peritonitis (HP:0002586) | 2.01306336 |
83 | Bone pain (HP:0002653) | 2.00693992 |
84 | Beaking of vertebral bodies (HP:0004568) | 2.00343704 |
85 | Abnormality of iron homeostasis (HP:0011031) | 1.98433936 |
86 | Retinal atrophy (HP:0001105) | 1.97830486 |
87 | * Neuronal loss in central nervous system (HP:0002529) | 1.97255831 |
88 | Cardiomegaly (HP:0001640) | 1.97129076 |
89 | * Progressive neurologic deterioration (HP:0002344) | 1.96580733 |
90 | Stomatitis (HP:0010280) | 1.92757219 |
91 | Supranuclear gaze palsy (HP:0000605) | 1.90267675 |
92 | Hemoptysis (HP:0002105) | 1.89873564 |
93 | Global brain atrophy (HP:0002283) | 1.89602555 |
94 | Tetraparesis (HP:0002273) | 1.87378621 |
95 | Petechiae (HP:0000967) | 1.87252961 |
96 | Restrictive lung disease (HP:0002091) | 1.86486935 |
97 | Progressive visual loss (HP:0000529) | 1.86088682 |
98 | Colitis (HP:0002583) | 1.86038185 |
99 | Gingival bleeding (HP:0000225) | 1.83911861 |
100 | Abnormality of the thoracic spine (HP:0100711) | 1.83464391 |
101 | Deformed sella turcica (HP:0002681) | 1.83322722 |
102 | Esophageal varix (HP:0002040) | 1.82883403 |
103 | Keratoconjunctivitis sicca (HP:0001097) | 1.81122021 |
104 | Abnormality of the nasal mucosa (HP:0000433) | 1.80784918 |
105 | Increased serum ferritin (HP:0003281) | 1.77638015 |
106 | Xanthomatosis (HP:0000991) | 1.76210638 |
107 | Premature loss of primary teeth (HP:0006323) | 1.75938710 |
108 | Amyloidosis (HP:0011034) | 1.75788477 |
109 | Recurrent pneumonia (HP:0006532) | 1.75454475 |
110 | Vasculitis (HP:0002633) | 1.74605656 |
111 | * Dementia (HP:0000726) | 1.74146280 |
112 | Polygenic inheritance (HP:0010982) | 1.74106365 |
113 | * Diminished motivation (HP:0000745) | 1.73825946 |
114 | Hypergammaglobulinemia (HP:0010702) | 1.73415786 |
115 | Epistaxis (HP:0000421) | 1.73325758 |
116 | Acrocyanosis (HP:0001063) | 1.73283038 |
117 | Distal lower limb muscle weakness (HP:0009053) | 1.72912649 |
118 | Nasal polyposis (HP:0100582) | 1.72416073 |
119 | Mucosal telangiectasiae (HP:0100579) | 1.72241072 |
120 | Arterial tortuosity (HP:0005116) | 1.71436061 |
121 | * Apathy (HP:0000741) | 1.70263257 |
122 | Inflammation of the large intestine (HP:0002037) | 1.70062766 |
123 | Increased CSF protein (HP:0002922) | 1.68197687 |
124 | Arterial thrombosis (HP:0004420) | 1.67522780 |
125 | Retrobulbar optic neuritis (HP:0100654) | 1.67330045 |
126 | Optic neuritis (HP:0100653) | 1.67330045 |
127 | Polyneuropathy (HP:0001271) | 1.67296667 |
128 | Gastrointestinal stroma tumor (HP:0100723) | 1.66800886 |
129 | Metaphyseal irregularity (HP:0003025) | 1.64123678 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ERN1 | 4.03515192 |
2 | BLK | 3.88777131 |
3 | TGFBR2 | 3.20279502 |
4 | KIT | 3.00177720 |
5 | TBK1 | 2.94346853 |
6 | TYK2 | 2.84137147 |
7 | TRIB3 | 2.81383855 |
8 | IRAK4 | 2.63462627 |
9 | PRPF4B | 2.56092897 |
10 | RIPK4 | 2.46499626 |
11 | MAP4K1 | 2.33093150 |
12 | TAOK2 | 2.10773256 |
13 | CSF1R | 2.09161169 |
14 | PIM2 | 2.00219466 |
15 | NME2 | 1.97901428 |
16 | IRAK3 | 1.94249036 |
17 | PKN2 | 1.92313315 |
18 | EPHB1 | 1.88783858 |
19 | TAOK1 | 1.84737667 |
20 | TAOK3 | 1.83115838 |
21 | MAP3K14 | 1.82219160 |
22 | DDR2 | 1.73094666 |
23 | CAMK1D | 1.64460871 |
24 | IKBKB | 1.62828917 |
25 | NEK9 | 1.59412656 |
26 | JAK1 | 1.58837095 |
27 | IKBKE | 1.53621176 |
28 | CSK | 1.52250687 |
29 | ZAP70 | 1.52066829 |
30 | PAK4 | 1.50862329 |
31 | STK10 | 1.49971795 |
32 | MAP2K3 | 1.47581839 |
33 | TTN | 1.42478114 |
34 | CDC42BPA | 1.36119577 |
35 | HCK | 1.34598028 |
36 | RIPK1 | 1.33171585 |
37 | JAK3 | 1.30220395 |
38 | SCYL2 | 1.24732307 |
39 | MAP3K1 | 1.22766198 |
40 | PTK6 | 1.22253195 |
41 | LRRK2 | 1.17370056 |
42 | FES | 1.16518271 |
43 | BTK | 1.14655775 |
44 | SMG1 | 1.14013284 |
45 | SYK | 1.12057643 |
46 | FGR | 1.11219148 |
47 | BMX | 1.11039379 |
48 | RPS6KA4 | 1.08768678 |
49 | ABL2 | 1.07134485 |
50 | ICK | 1.06426877 |
51 | LYN | 1.02738834 |
52 | FGFR4 | 1.00528773 |
53 | JAK2 | 1.00377663 |
54 | BMPR2 | 1.00055144 |
55 | MATK | 0.99406869 |
56 | SIK3 | 0.97977158 |
57 | MAP3K3 | 0.97386968 |
58 | CAMKK2 | 0.96811770 |
59 | ARAF | 0.95927860 |
60 | CAMK1G | 0.95318476 |
61 | CDK6 | 0.91680887 |
62 | LCK | 0.88729931 |
63 | TNK2 | 0.88241164 |
64 | DMPK | 0.84633385 |
65 | PRKD2 | 0.83280632 |
66 | TEC | 0.82209878 |
67 | GRK7 | 0.81312761 |
68 | ITK | 0.80245041 |
69 | IRAK2 | 0.76420225 |
70 | PIM1 | 0.76350098 |
71 | PBK | 0.74652902 |
72 | EPHA2 | 0.74224442 |
73 | MOS | 0.73773831 |
74 | EGFR | 0.73163628 |
75 | PDGFRA | 0.72681207 |
76 | CHUK | 0.72655033 |
77 | MST1R | 0.72283810 |
78 | MAP3K11 | 0.71562184 |
79 | RPS6KA2 | 0.70634772 |
80 | KDR | 0.69601321 |
81 | SIK1 | 0.64879334 |
82 | ABL1 | 0.64497125 |
83 | CAMKK1 | 0.64450958 |
84 | MAP3K5 | 0.64396323 |
85 | MAP3K6 | 0.64157874 |
86 | TRPM7 | 0.63695634 |
87 | EPHB2 | 0.63551945 |
88 | MARK3 | 0.61598465 |
89 | RPS6KL1 | 0.59947859 |
90 | RPS6KC1 | 0.59947859 |
91 | EPHA3 | 0.59866443 |
92 | MARK2 | 0.59006285 |
93 | MAPK7 | 0.58571325 |
94 | KSR2 | 0.58182893 |
95 | FLT3 | 0.57980405 |
96 | PRKG2 | 0.57402112 |
97 | CLK1 | 0.55753217 |
98 | PIK3CG | 0.55722735 |
99 | GSK3A | 0.55426500 |
100 | PDK1 | 0.55385593 |
101 | LIMK1 | 0.54342121 |
102 | PRKCD | 0.53880195 |
103 | FGFR3 | 0.53780627 |
104 | MAP3K13 | 0.52089206 |
105 | STK3 | 0.50295547 |
106 | TESK2 | 0.49045860 |
107 | MAP2K6 | 0.48274815 |
108 | GRK6 | 0.46963070 |
109 | HIPK2 | 0.46163302 |
110 | MAP3K10 | 0.45360899 |
111 | MAPKAPK2 | 0.43810360 |
112 | MAP3K8 | 0.42859082 |
113 | DYRK1B | 0.42192342 |
114 | PAK2 | 0.38855615 |
115 | IGF1R | 0.37676360 |
116 | DAPK3 | 0.37673082 |
117 | MAPK12 | 0.37636661 |
118 | STK4 | 0.36727532 |
119 | IRAK1 | 0.36139656 |
120 | MAPK4 | 0.34338672 |
121 | TXK | 0.33956887 |
122 | PDPK1 | 0.33237822 |
123 | MAP2K2 | 0.33017680 |
124 | SIK2 | 0.32971647 |
125 | TESK1 | 0.32612838 |
126 | FYN | 0.31900721 |
127 | RPS6KA6 | 0.31233532 |
128 | PAK1 | 0.30515684 |
129 | PDGFRB | 0.29836763 |
130 | PTK2 | 0.29205194 |
131 | PTK2B | 0.27589655 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 4.49797825 |
2 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 4.39490514 |
3 | Lysosome_Homo sapiens_hsa04142 | 3.83366384 |
4 | Other glycan degradation_Homo sapiens_hsa00511 | 3.58515747 |
5 | Leishmaniasis_Homo sapiens_hsa05140 | 2.89936934 |
6 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.43229575 |
7 | Pertussis_Homo sapiens_hsa05133 | 2.29088009 |
8 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.29046241 |
9 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.08222531 |
10 | Tuberculosis_Homo sapiens_hsa05152 | 2.07653468 |
11 | Malaria_Homo sapiens_hsa05144 | 2.02191983 |
12 | Phagosome_Homo sapiens_hsa04145 | 2.00014680 |
13 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.92451684 |
14 | Legionellosis_Homo sapiens_hsa05134 | 1.77096145 |
15 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.76333877 |
16 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.65168886 |
17 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.59484552 |
18 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.55110538 |
19 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.51712189 |
20 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.49007056 |
21 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.44829811 |
22 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.44012663 |
23 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.43504097 |
24 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.42829087 |
25 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.41130918 |
26 | Measles_Homo sapiens_hsa05162 | 1.38012233 |
27 | Salmonella infection_Homo sapiens_hsa05132 | 1.31784006 |
28 | Apoptosis_Homo sapiens_hsa04210 | 1.31691979 |
29 | Shigellosis_Homo sapiens_hsa05131 | 1.31495671 |
30 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.25241480 |
31 | Influenza A_Homo sapiens_hsa05164 | 1.22609306 |
32 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.22530663 |
33 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.21569371 |
34 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.18770722 |
35 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.11433498 |
36 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.10541681 |
37 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.09621737 |
38 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.07877731 |
39 | Bladder cancer_Homo sapiens_hsa05219 | 1.07152273 |
40 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.06628703 |
41 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.05628562 |
42 | Amoebiasis_Homo sapiens_hsa05146 | 1.05116136 |
43 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.02551979 |
44 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.96665633 |
45 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.96636704 |
46 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.96516625 |
47 | Prion diseases_Homo sapiens_hsa05020 | 0.93608124 |
48 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.91824567 |
49 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.91501951 |
50 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.90900806 |
51 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.89796170 |
52 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.89774157 |
53 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.87923742 |
54 | Hepatitis B_Homo sapiens_hsa05161 | 0.87629214 |
55 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.87236659 |
56 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.85244541 |
57 | Asthma_Homo sapiens_hsa05310 | 0.84267733 |
58 | Hepatitis C_Homo sapiens_hsa05160 | 0.83980056 |
59 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.81956184 |
60 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.81292665 |
61 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.77336893 |
62 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.75360562 |
63 | Platelet activation_Homo sapiens_hsa04611 | 0.71869003 |
64 | Viral myocarditis_Homo sapiens_hsa05416 | 0.71583567 |
65 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.70972547 |
66 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.70149954 |
67 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.64396174 |
68 | Endocytosis_Homo sapiens_hsa04144 | 0.62804078 |
69 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.62717936 |
70 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.60124816 |
71 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.59589768 |
72 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.59107858 |
73 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.54461066 |
74 | Galactose metabolism_Homo sapiens_hsa00052 | 0.53506905 |
75 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.53336790 |
76 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.53298002 |
77 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.53070734 |
78 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.52747268 |
79 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.51550259 |
80 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.51491060 |
81 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.50402931 |
82 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.47772565 |
83 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.47704552 |
84 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.47483911 |
85 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.46990489 |
86 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.46736068 |
87 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.45737726 |
88 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.45285865 |
89 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.44867935 |
90 | HTLV-I infection_Homo sapiens_hsa05166 | 0.44162977 |
91 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.43092581 |
92 | Focal adhesion_Homo sapiens_hsa04510 | 0.42339377 |
93 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.38709545 |
94 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.38555110 |
95 | Mineral absorption_Homo sapiens_hsa04978 | 0.38202422 |
96 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.37739192 |
97 | Allograft rejection_Homo sapiens_hsa05330 | 0.36995578 |
98 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.36196279 |
99 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.35893605 |
100 | Insulin resistance_Homo sapiens_hsa04931 | 0.35275211 |
101 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.34411838 |
102 | ABC transporters_Homo sapiens_hsa02010 | 0.33780540 |
103 | Histidine metabolism_Homo sapiens_hsa00340 | 0.33261215 |
104 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.31201409 |
105 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.31027909 |
106 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.30350654 |
107 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.29809733 |
108 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.29081736 |
109 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.28815192 |
110 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.28798836 |
111 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.28597202 |
112 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.28225283 |
113 | Adherens junction_Homo sapiens_hsa04520 | 0.26031404 |
114 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.25733067 |
115 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.25439188 |
116 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.24671113 |
117 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.22564284 |